Xconomy |
GSK, Propeller Health partner to study smart inhalers for asthma, COPD drugs
FierceMedicalDevices (press release) (registration) Fierce 15 company Propeller Health has announced an R&D collaboration with GlaxoSmithKline ($GSK), under which it will design and manufacture a custom sensor for the Ellipta inhaler to be used in GSK clinical studies of asthma and COPD. The goal is to … GSK, Propeller Health Ink R&D Deal For Custom Respiratory Device Propeller Health Announces Development Agreement and R&D Collaboration with … Propeller Health, GSK to Develop Digital Sensor for Ellipta® Inhaler |
View full post on asthma – Google News